The evolving biosimilar regulations in the United States are poised to create new growth opportunities for Indian pharmaceutical companies, with experts predicting a significant uptick in exports and partnerships in the biopharma segment.The U.S. Food and Drug Administration’s (FDA) streamlined approval pathway for biosimilars, along
The Indian Pharmaceutical Alliance (IPA) has announced the appointment of Dr. Sharvil Patel, Managing Director of Zydus Lifesciences, as its new President. Dr. Patel will lead the industry body for the next two years, succeeding Samina Hamied, Executive Vice Chairperson of Cipla Ltd., who successfully
The healthcare and life sciences sectors are now bracing for global ripple effects as the Trump administration, under President Donald J. Trump’s second term, enforces a new round of tariffs targeting imports from key trade partners, including India and China. The proposed 25% tariff on
Need to add 30 lakh new hospital beds; aim to reach 100% health insurance coverage to achieve India’s healthcare vision 2047Mr Apurva Chandra, Secretary, Health & Family Welfare, Government of India today released the FICCI-EY report - ‘Decoding India’s Healthcare Landscape’. The report highlights
